ໜ້າທຳອິດNOVN • SWX
add
Novartis AG
ປິດກ່ອນໜ້າ
CHF 91,56
ຂອບເຂດລາຄາໃນມື້
CHF 92,04 - CHF 93,99
ຂອບເຂດລາຄາໃນປີ
CHF 83,63 - CHF 102,72
ມູນຄ່າຮຸ້ນຕາມລາຄາຕະຫຼາດ
205,76 ຕື້ CHF
ປະລິມານສະເລ່ຍ
2,97 ລ້ານ
ອັດຕາ P/E
12,39
ເງິນປັນຜົນ
3,52%
ຕະຫຼາດຂັ້ນຕົ້ນ
SWX
ໃນຂ່າວ
ການເງິນ
ໃບລາຍງານຜົນໄດ້ຮັບ
ລາຍໄດ້
ລາຍໄດ້ສຸດທິ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ | 13,17 ຕື້ | 8,93% |
ຄ່າໃຊ້ຈ່າຍການດຳເນີນການ | 5,52 ຕື້ | -24,45% |
ລາຍໄດ້ສຸດທິ | 3,19 ຕື້ | 81,09% |
ສ່ວນແບ່ງກຳໄລສຸດທິ | 24,21 | 66,28% |
ລາຍໄດ້ຕໍ່ຮຸ້ນ | 2,06 | 18,39% |
EBITDA | 5,50 ຕື້ | 88,62% |
ອັດຕາອາກອນທີ່ມີຜົນ | 5,91% | — |
ໃບດຸ່ນດ່ຽງ
ຊັບສິນທັງໝົດ
ໜີ້ສິນທັງໝົດ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ເງິນສົດ ແລະ ລົງທຶນໄລຍະສັ້ນ | 13,85 ຕື້ | 8,08% |
ຊັບສິນທັງໝົດ | 103,52 ຕື້ | -8,14% |
ໜີ້ສິນທັງໝົດ | 60,08 ຕື້ | -19,30% |
ຫຸ້ນທຶນທັງໝົດ | 43,44 ຕື້ | — |
ຮຸ້ນທີ່ຄ້າງຈ່າຍ | 2,00 ຕື້ | — |
ລາຄາຕໍ່ມູນຄ່າທາງບັນຊີ | 4,23 | — |
ລາຍຮັບຈາກຊັບສິນ | 10,97% | — |
ລາຍຮັບຈາກທຶນ | 15,05% | — |
ກະແສເງິນສົດ
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ
(USD) | ກ.ຍ. 2024info | ການປ່ຽນແປງ ປ/ປ |
---|---|---|
ລາຍໄດ້ສຸດທິ | 3,19 ຕື້ | 81,09% |
ເງິນສົດຈາກການດໍາເນີນງານ | 6,29 ຕື້ | 16,88% |
ເງິນສົດຈາກການລົງທຶນ | -374,00 ລ້ານ | 83,09% |
ເງິນສົດຈາກການເງິນ | -382,00 ລ້ານ | 54,09% |
ການປ່ຽນແປງສຸດທິເປັນເງິນສົດ | 5,71 ຕື້ | 275,39% |
ການເງິນສະພາບຄ່ອງ | 4,55 ຕື້ | -63,57% |
ກ່ຽວກັບ
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes”.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
ສ້າງຕັ້ງ
29 ກ.ພ. 1996
ສໍານັກງານໃຫຍ່
ເວັບໄຊ
ພະນັກງານ
76.057